A nasal sample was collected from Javier Sanchez Martinez on January 30, 2022 and tested for SARS-CoV-2 using the Standard Q COVID-19 Ag Test. The test result was negative, indicating viral proteins from SARS-CoV-2 were not detected. While a negative result makes infection less likely, it does not rule out the possibility of infection within the first week of exposure. The test has a documented sensitivity of 93.12% and specificity of 100%.
A nasal sample was collected from Javier Sanchez Martinez on January 30, 2022 and tested for SARS-CoV-2 using the Standard Q COVID-19 Ag Test. The test result was negative, indicating viral proteins from SARS-CoV-2 were not detected. While a negative result makes infection less likely, it does not rule out the possibility of infection within the first week of exposure. The test has a documented sensitivity of 93.12% and specificity of 100%.
A nasal sample was collected from Javier Sanchez Martinez on January 30, 2022 and tested for SARS-CoV-2 using the Standard Q COVID-19 Ag Test. The test result was negative, indicating viral proteins from SARS-CoV-2 were not detected. While a negative result makes infection less likely, it does not rule out the possibility of infection within the first week of exposure. The test has a documented sensitivity of 93.12% and specificity of 100%.
I hereby issue to you the following result of a nasal sample for the diagnosis of VIRAL RESPIRATORY DISEASE, with the test device for COVID-19 Ag Test for the new Coronavirus.
PATIENT NAME: SANCHEZ MARTINEZ JAVIER
SEX: MALE DATE OF BIRTH: AUG/30/1975 AGE: 46 YEARS KIT BRAND: STANDARD Q COVID-19 Ag Test CATALOG NO. Q-NCOV-01G MANUFACTURER: SD BIOSENSOR ANTIGEN DETECTED: VIRAL PROTEINS TAKE DATE: JAN/30/2022 TIME: 15:48PM RESULT: Ag Test ……………. NEGATIVE ORIGIN OF SAMPLE: NASOPHARYNX INTERNAL FOLIO: OA0835 PERFORMED BY: DR. JORGE OLIVEROS QUEZADA On December 11, 2020, COFEPRIS approved the use of antigenic tests in order to complement an accurate diagnosis in a timely manner. The presence of antigens type "Viral Proteins" of SARS CoV 2, determines the exposure to the virus, a negative result does not exclude the probability of infection within the first week of this (incubation period). The internationally documented sensitivity of this reagent is 93.12% (95% CI, 88.03% - 96.52%) and a specificity of 100% (95% CI, 98.17% -100%).